Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Kern

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2004
[Body weight regulation through the central nervous system. The development of a pathogenetically based adiposity therapy]Lorenz Fehm, Werner Kern, Achim Peters
Expert Opinion on Drug Delivery|August 9, 2007
Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administrationManfred Hallschmid, Christian Benedict, Jan Born, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2008
Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulinChristian Benedict, Werner Kern, Bernd Schultes, et al.
Neuroendocrinology|July 24, 2007
Intranasal insulin to improve memory function in humansChristian Benedict, Manfred Hallschmid, Bernd Schultes, et al.
Metabolism: Clinical and Experimental|March 1, 2005
Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemiaWerner Kern, Achim Peters, Jan Born, et al.
Physiology & Behavior|October 27, 2004
Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in manManfred Hallschmid, Christian Benedict, Jan Born, et al.
Diabetes|December 20, 2008
Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humansManfred Hallschmid, Harpal Randeva, Bee K Tan, et al.
Journal of Medical Economics|December 17, 2009
Costs of managing severe hypoglycaemia in three European countriesMette Hammer, Morten Lammert, Susana Monereo Mejías, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatmentBee K Tan, Manfred Hallschmid, Werner Kern, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 28, 2017
Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT StudyWerner Kern, Andreas Holstein, Christian Moenninghoff, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2004
[Body weight regulation through the central nervous system. The development of a pathogenetically based adiposity therapy]Lorenz Fehm, Werner Kern, Achim Peters
Expert Opinion on Drug Delivery|August 9, 2007
Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administrationManfred Hallschmid, Christian Benedict, Jan Born, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2008
Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulinChristian Benedict, Werner Kern, Bernd Schultes, et al.
Neuroendocrinology|July 24, 2007
Intranasal insulin to improve memory function in humansChristian Benedict, Manfred Hallschmid, Bernd Schultes, et al.
Metabolism: Clinical and Experimental|March 1, 2005
Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemiaWerner Kern, Achim Peters, Jan Born, et al.
Physiology & Behavior|October 27, 2004
Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in manManfred Hallschmid, Christian Benedict, Jan Born, et al.
Diabetes|December 20, 2008
Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humansManfred Hallschmid, Harpal Randeva, Bee K Tan, et al.
Journal of Medical Economics|December 17, 2009
Costs of managing severe hypoglycaemia in three European countriesMette Hammer, Morten Lammert, Susana Monereo Mejías, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatmentBee K Tan, Manfred Hallschmid, Werner Kern, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 28, 2017
Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT StudyWerner Kern, Andreas Holstein, Christian Moenninghoff, et al.
Pageof 4